BiomX Inc. — Director's Dealing 2023

Oct 31, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2023-10-29

Reporting Person: Oron Assaf (Chief Business Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-10-29	Common Stock Options - Right to Buy	$1.691	D	155363	Disposed	2027-03-26	Common Stock (0)	Direct
2023-10-29	Common Stock Options - Right to Buy	$0.275	A	155363	Acquired	2027-03-26	Common Stock (0)	Direct
2023-10-29	Common Stock Options - Right to Buy	$1.973	D	82667	Disposed	2028-05-22	Common Stock (0)	Direct
2023-10-29	Common Stock Options - Right to Buy	$0.275	A	82667	Acquired	2028-05-22	Common Stock (0)	Direct
2023-10-29	Common Stock Options - Right to Buy	$2.031	D	46966	Disposed	2029-03-29	Common Stock (0)	Direct
2023-10-29	Common Stock Options - Right to Buy	$0.275	A	46966	Acquired	2029-03-29	Common Stock (0)	Direct

Footnotes

F1: The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 03/26/2017 and provides for vesting over four years, with 25% of the shares subject to the option vested on 03/26/2018, and the remainder vested in 12 equal quarterly installments over three years; provided, however, none of the "new" options may be exercised prior to October 29, 2024.

F2: The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 05/22/2018 and provides for vesting over four years, with 25% of the shares subject to the option vested on 05/22/2019, and the remainder vested in 12 equal quarterly installments over three years; provided, however, none of the "new" options may be exercised prior to October 29, 2024.

F3: The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 03/29/2019 and provides for vesting over four years, with 25% of the shares subject to the option vested on 03/29/2020, and the remainder vested in 12 equal quarterly installments over three years; provided, however, none of the "new" options may be exercised prior to October 29, 2024.